DIVISLAB.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Stats
Šios dienos apimtis	1.15M
Vidutinė apimtis	548 796
Rinkos kapitalizacija	1 066.22B
EPS	INR0 ( 2024-02-10 )
Kita pelno data	( INR0 ) 2024-05-17
Last Dividend	INR30.00 ( 2023-08-10 )
Next Dividend	INR0 ( N/A )
P/E	76.82
ATR14	INR4.43 (0.11%)

Tūris Koreliacija

Ilgas: 0.47 (neutral)

Trumpas: 0.94 (very strong)

Signal:(47.018) Expect same movement, but be aware

Divi's Laboratories Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
KHAICHEM.NS	0.898
STAR.NS	0.897
20MICRONS.NS	0.891
IGPL.NS	0.872
HIL.NS	0.871
SANGHIIND.NS	0.865
DBREALTY.NS	0.864
AYMSYNTEX.NS	0.863
GRANULES.NS	0.857
KUANTUM.NS	0.857

10 Labiausiai neigiamai susiję koreliacijos
RAJRILTD.NS	-0.879
PERSISTENT.NS	-0.846
GNA.NS	-0.83
GTNIND.NS	-0.829
4THDIM.NS	-0.824
LTGILTBEES.NS	-0.824
SRTRANSFIN.NS	-0.82
ACI.NS	-0.819
ICICIBANKN.NS	-0.81
RADICO.NS	-0.801

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Divi's Laboratories Koreliacija - Valiuta/Žaliavos

0.83
( strong )

0.57
( weak )

-0.66
( moderate negative )

0.77
( moderate )

0.32
( neutral )

0.14
( neutral )

Divi's Laboratories Finansinės ataskaitos

Annual	2022
Pajamos:	INR77.68B
Bruto pelnas:	INR47.14B (60.69 %)
EPS:	INR68.69

FY	2022
Pajamos:	INR77.68B
Bruto pelnas:	INR47.14B (60.69 %)
EPS:	INR68.69

FY	2022
Pajamos:	INR87.99B
Bruto pelnas:	INR58.32B (66.28 %)
EPS:	INR111.52

FY	2021
Pajamos:	INR68.58B
Bruto pelnas:	INR45.34B (66.11 %)
EPS:	INR74.75

Financial Reports:

No articles found.

Divi's Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR30.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR30.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Divi's Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.40 - low (13.17%) | Divividend Growth Potential Score: 3.51 - Decrease likely (29.72%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.300	2003-08-11
Last Dividend	INR30.00	2023-08-10
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	21	--
Total Paid Out	INR188.60	--
Avg. Dividend % Per Year	0.49%	--
Score	1.94	--
Div. Sustainability Score	3.40
Div.Growth Potential Score	3.51
Div. Directional Score	3.46	--

Next Divdend (Est)
(2024-06-27)

INR32.66 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.94

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR10.00	0.83%
2019	INR16.00	1.08%
2020	INR16.00	0.88%
2021	INR20.00	0.52%
2022	INR30.00	0.65%
2023	INR30.00	0.89%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SSWL.NS	Dividend Junior	2023-08-14	Annually	20	0.30%
MSUMI.NS	Dividend Junior	2023-08-09	Annually	3	0.60%
HIKAL.NS	Dividend Junior	2023-09-18	Semi-Annually	23	0.37%
BLUEDART.NS	Dividend Junior	2023-07-19	Annually	22	0.45%
REDINGTON.NS	Dividend Knight	2023-07-06	Annually	18	3.28%
KPITTECH.NS	Dividend Knight	2023-08-14	Annually	6	0.47%
FACT.NS	Dividend Junior	2023-09-22	Insufficient data to determine frequency	2	0.09%
AMRUTANJAN.NS	Dividend Junior	2023-09-14	Semi-Annually	15	0.38%
TASTYBITE.NS	Dividend Junior	2023-07-14	Annually	8	0.01%
NH.NS	Dividend Junior	2023-07-06	Sporadic	6	0.14%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.185	1.500	6.30	9.44	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.109	1.500	9.90	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1 546.55	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	27.88	2.00	0.708	1.416	[0 - 30]
freeCashFlowPerShareTTM	27.88	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.592	1.000	3.46	3.46	[0.2 - 0.8]
operatingProfitMarginTTM	0.256	1.000	6.88	6.88	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.40

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	76.82	1.000	2.34	0	[1 - 100]
returnOnEquityTTM	0.109	2.50	9.94	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	27.88	2.00	0.708	10.00	[0 - 30]
dividendYielPercentageTTM	0.747	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	27.88	2.00	0.708	1.416	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.20	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0988	1.000	-0.0308	0	[0.1 - 0.5]
Total Score				3.51

Divi's Laboratories

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.